ClinicalTrials.gg
SupplementDrug

Lactiplantibacillus plantarum 299V clinical trials

Also written Lactobacillus plantarum 299v, Lp 299v and DSM 9843.

studies test it
7
open now
2
in phase 3
1
first study started
2011

Counted the way a researcher would: Lactiplantibacillus plantarum 299V with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses lactiplantibacillus plantarum 299V is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the lactiplantibacillus plantarum 299V studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

LACTIPLANTIBACILLUS PLANTARUM 299V
2

Development codes

Lp 299v
3
DSM 9843
2

Other names

Lactobacillus plantarum 299v
4
Lactobacillus plantarum strain 299v
2

Studies by the year they started

7 studies that test it; most in 2026 (2)

Studies that test lactiplantibacillus plantarum 299V, by start year
YearStudies
20111
20121
20141
20181
20191
20262

By phase

A phase 1/2 study counts in both.

Phase 2
4
Phase 3
1
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 0 · Other 7

Children's Oncology Group (1) · Medical University of Gdansk (1) · Medical University of Bialystok (1) · University of Stellenbosch (1) · University of Illinois Chicago (1) · Massachusetts Eye and Ear Infirmary (1) · Stanford University (1)

Often tested with

Tested in the same studies.

Lactobacillus plantarum 299 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test lactiplantibacillus plantarum 299V.

Studies

Open first, then newest update. How each study uses lactiplantibacillus plantarum 299V is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 7

Codes

What other systems call lactiplantibacillus plantarum 299V · ClinicalTrials.gg INT017585

  • UNII (FDA) PH2Q4E64WMLACTIPLANTIBACILLUS PLANTARUM 299VOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.